Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study
dc.conference.date | SEP 19-OCT 18, 2020 | |
dc.conference.title | ESMO Virtual Congress | |
dc.contributor.author | Lozano Mejorada, R. | |
dc.contributor.author | Castro Marcos, E. | |
dc.contributor.author | Aragon, I. M. | |
dc.contributor.author | Thorne, H. | |
dc.contributor.author | Lopez Campos, F. | |
dc.contributor.author | Sanz, A. | |
dc.contributor.author | Alonso, C. | |
dc.contributor.author | Anido, U. | |
dc.contributor.author | Juan Fita, M. J. | |
dc.contributor.author | Gutierrez Pecharroman, A. M. | |
dc.contributor.author | Ramirez-Backhaus, M. | |
dc.contributor.author | Balmana, J. | |
dc.contributor.author | Chirivella Gonzalez, I. | |
dc.contributor.author | Llort, G. | |
dc.contributor.author | Romero Laorden, N. | |
dc.contributor.author | Arevalo Lobera, S. | |
dc.contributor.author | Rubio Briones, J. | |
dc.contributor.author | Pritchard, C. C. | |
dc.contributor.author | Sandhu, S. | |
dc.contributor.author | Olmos Hidalgo, D. | |
dc.contributor.authoraffiliation | [Lozano Mejorada, R.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain | |
dc.contributor.authoraffiliation | [Aragon, I. M.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain | |
dc.contributor.authoraffiliation | [Sanz, A.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain | |
dc.contributor.authoraffiliation | [Olmos Hidalgo, D.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain | |
dc.contributor.authoraffiliation | [Castro Marcos, E.] Hosp Univ Virgen de la Victoria, Med Oncol, Malaga, Spain | |
dc.contributor.authoraffiliation | [Castro Marcos, E.] Inst Invest Biomed Malaga, Malaga, Spain | |
dc.contributor.authoraffiliation | [Thorne, H.] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia | |
dc.contributor.authoraffiliation | [Sandhu, S.] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia | |
dc.contributor.authoraffiliation | [Lopez Campos, F.] Hosp Univ Ramon y Cajal, Radiat Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Alonso, C.] Hosp Univ Princesa, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Anido, U.] CHUS Complejo Hosp Univ Santiago de Compostela SE, Med Oncol Dept, Santiago De Compostela, La Coruna, Spain | |
dc.contributor.authoraffiliation | [Juan Fita, M. J.] Fdn Inst Valenciano Oncol, Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Gutierrez Pecharroman, A. M.] Hosp Getafe, Pathol, Getafe, Spain | |
dc.contributor.authoraffiliation | [Ramirez-Backhaus, M.] Fdn Inst Valenciano Oncol, Urol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Rubio Briones, J.] Fdn Inst Valenciano Oncol, Urol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Balmana, J.] Vall dHebron Univ Hosp, Dept Med Oncol, Hereditary Canc Genet Grp 4, VHIO, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Chirivella Gonzalez, I.] Hosp Clin Univ Valencia, Med Oncol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Llort, G.] Corp Sanitaria Univ, Hereditary Canc Unit 8, Parc Tauli Sabadell, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Llort, G.] Corp Sanitaria Univ, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Romero Laorden, N.] Hosp Univ Princesa, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Arevalo Lobera, S.] Hosp Donostia, Med Oncol Dept, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Pritchard, C. C.] Univ Washington, Lab Med, Seattle, WA 98195 USA | |
dc.contributor.funder | CRIS Foundation | |
dc.contributor.funder | Prostate Cancer Foundation | |
dc.contributor.funder | PCF Foundation | |
dc.date.accessioned | 2025-01-07T15:10:40Z | |
dc.date.available | 2025-01-07T15:10:40Z | |
dc.date.issued | 2020-09-01 | |
dc.identifier.doi | 10.1016/j.annonc.2020.08.872 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753420408683/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/26935 | |
dc.identifier.wosID | 573469100610 | |
dc.issue.number | 4 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen de la Victoria | |
dc.organization | Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA) | |
dc.page.number | S509-S510 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 31 | |
dc.wostype | Meeting Abstract |